Apollo Therapeutics, a biopharmaceutical company, has successfully concluded its Series C financing with a second close, securing an additional $33.5 million (approximately €30.52 million).
Copyright © 2023. Founders Today. All rights reserved
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?